Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03NPI
|
|||
| Drug Name |
Idecabtagene vicleucel
|
|||
| Synonyms |
Bb2121
Click to Show/Hide
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Approved | [1] | |
| Company |
Celgene
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | B-cell maturation protein (TNFRSF17) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.